Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Johnson & Johnson    JNJ   US4781601046

JOHNSON & JOHNSON

 (JNJ)

89
Real-time Quote. Real-time BATS US - 05/23 04:59:59 pm
87.265 USD   -1.35%
1d agoDJ4TH UPDATE: J&J to Submit More Than 10 New Drug Applications by 2017
1d agoDJJ&J to Submit More Than 10 New Drug Applications by 2017
1d agoDJJ&J to Submit Over 10 New Drug Applications by 2017
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisionsForum 
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Pharmaceuticals - Diversified
Logo
Logo Johnson & Johnson
Business Summary
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:
- medical products and equipment (40.8%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;
- pharmaceutical products (37.7%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, immunological, neurological, dermatological diseases, etc.;
- products for consumption by the general public (21.5%): OTC drugs, ophthalmological products (world's No. 1 producer of soft contact lenses; Acuvue brand), nutritional products, personal care products (RoC, Neutrogena brands, etc.), feminine hygiene and baby care products, etc.
Net sales break down geographically as follows: the United States (44.4%), Europe (25.2%), Asia/Pacific and Africa (19.7%) and other (10.7%).
Surperformance© rating of Johnson & Johnson
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Pharmaceuticals - Diversified
CountryTrading RatingInvestor Rating
JOHNSON & JOHNSONUSA
ROCHE HOLDING LTD.Switzerland
PFIZER INC.USA
NOVARTIS AGSwitzerland
SANOFIFrance
MERCK & CO., INC.USA
GLAXOSMITHKLINE PLCUnited Kingdom
BAYER AGGermany
BRISTOL MYERS SQUIBB CO.USA
NOVO NORDISK A/SDenmark
ELI LILLY & CO.USA
ABBOTT LABORATORIESUSA
TEVA PHARMACEUTICAL INDUSTRIES LIMITEDISRAEL
ALEXION PHARMACEUTICALS, INC.USA
SHIRE PLCUnited Kingdom
ACTAVIS INCUSA
CHUGAI PHARMACEUTICAL CO., LTD.Japan
DAIICHI SANKYO COMPANY, LIMITEDJapan
MYLAN INC.USA
UCBBelgium
BIOMARIN PHARMACEUTICAL INC.USA
TASLY PHARMACEUTICAL GROUP CO LTDCHINA
TAISHO PHARMACEUTICAL HOLDINGS CO LTDJapan
WARNER CHILCOTT PLCUSA
HISAMITSU PHARMACEUTICAL CO., INC.Japan
Sector Pharmaceuticals - Diversified
Data source :
© 2013 Thomson Reuters
Ratings :
© 2013 Surperformance
Shareholders
- State Street Corporation 5,10%
- Blackrock 5,60%
Advertisement
Managers
- Chief Financial Officer :
    Dominic J. Caruso
- General Secretary :
    Douglas K. Chia
- Chief Executive Officer :
    Alex Gorsky
Company contact information
One plaza Johnson
NJ 08933 New Brunswick
USA

Phone : +1 (732) 524 0400
Fax : +1
Internet : http://www.jnj.com
Markets and indexes
- NYSE Euronext
- Main Market
- DJIA / SP100, SP500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- ISIN Code :  US4781601046
- Bloomberg Code :  JNJ:US
- Reuters Code :  JNJ
- Datastream Code :  U:JNJ
Financial data source :
© 2013 Cofisem
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.